免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1D

NCT:NCT07593625 · RECRUITING

NCT IDNCT07593625
狀態RECRUITING
開始日期2026-05-25
完成時間2027-02-01
SponsorInsulet Corporation (INDUSTRY)
First posted
Last updated

簡要摘要

Feasibility study to evaluate the safety and feasibility of Omnipod automated insulin delivery algorithms in individuals with type 1 diabetes. This study will enroll up to 80 participants to have a minimum of 48 participants to initiate the use of Omnipod. The study will include hotel and outpatient evaluation periods.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑